Know Cancer

or
forgot password

Management of Nausea and Vomiting Chemotherapy-induced in Normandy


N/A
18 Years
N/A
Not Enrolling
Both
Cancer, Nausea, Vomiting

Thank you

Trial Information

Management of Nausea and Vomiting Chemotherapy-induced in Normandy


Inclusion Criteria:



- Aged over 18 years

- With solid tumors or hematologic in first line chemotherapy, administered
intravenously,

- Able to understand the meaning of the questions

- Having given their written consent to participate in the survey.

Exclusion Criteria:

This does not concern patients who:

- Do not give their consent for participation

- Do not speak French

- Suffer from cognitive deficits

- Are under therapy

- Must receive a combination of radio-chemotherapy

- Present an occlusive syndrome

- Metastases (s) brain (s) clinically symptomatic (s) or radiologically proven (s) or a
(of) tumor (s) brain (s)

- Have been previously treated with chemotherapy

- Present a cons-indication to corticosteroids, with anti-serotonin or NK1 receptor
inhibitors

- Pregnant or breastfeeding.

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Outcome Measure:

acute nausea and vomiting

Outcome Description:

acute nausea and vomiting and / or delayed measured by the tool of anti emetic MAT MASCC.

Outcome Time Frame:

2 years

Safety Issue:

No

Principal Investigator

JOLY Florence, Pr

Investigator Role:

Principal Investigator

Investigator Affiliation:

Centre François Baclesse

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

NAVI

NCT ID:

NCT01440465

Start Date:

July 2011

Completion Date:

February 2013

Related Keywords:

  • Cancer
  • Nausea
  • Vomiting
  • chemotherapy
  • cancer
  • nausea
  • vomiting
  • Nausea
  • Vomiting

Name

Location